Insys Therapeutics Releases Statement on Its Patient Services Center

Insys Therapeutics, Inc.

("Insys" or "the Company") today issued the following statement in response to misleading reports in the media regarding the practices of its Patient Services Center: "Insys is committed to working with health care providers, insurance companies, payors, pharmacies, and most importantly, patients, to help ensure that patients have access to the Company's breakthrough cancer pain drug, Subsys®, a product that has helped and continues to help many patients suffering from excruciating pain related to certain cancers and cancer treatments.  "As for many specialty drugs, the path patients must travel to obtain third-party payor access and reimbursement can be complex and difficult to navigate. Insys' Patient Services Center is a group of dedicated employees who are committed to helping patients navigate this complex environment in order to access the medications that their practicing health care provider has deemed appropriate or necessary for their treatment. These support services initiate with patient consent at the time a prescription is written, and may continue according to the patient's needs."Insys requires its Patient Services Center personnel undergo specific training on applicable laws and regulations and continues to strive to